Overall, vaccines are highly effective, but some folks are at risk for poorer response. Studies of COVID-19 outcomes among people living with HIV have yielded conflicting results, but some show that HIV-positive people are at greater risk for severe illness and death. Many people with HIV are older and have other chronic health conditions, and
How Well Do COVID Vaccines Work for People With HIV? Read More »
On December 1st we celebrate World AIDS Day, an opportunity to reflect on our challenges and successes four decades into the battle against HIV/AIDS. Around the world there are nearly 38 million people living with HIV and about 1.5 million new infections per year. A recent report by the World Health Organization estimates the number
BC’s success story shows strength of Treatment as Prevention Read More »
BC Centre for Excellence in HIV/AIDS (BC-CfE) researchers, collaborating with counterparts at Simon Fraser University, the University of BC, Providence Health Care and the CIHR Canadian HIV Trials Network (CTN) recently published a study looking at COVID-19 vaccine immune responses in people living with HIV (PLWH). Due to the explosive growth of COVID-19 variants, and
A BC Centre for Excellence in HIV/AIDS (BC-CfE) research team is working to evaluate how a new primary care clinic can keep clients engaged in health care among residents of Vancouver’s Downtown East Side (DTES). The “Hope to Health Engagement and Retention Evaluation (HERE) Study” is being conducted from the Hope to Health (H2H) Research
Improving patient engagement and retention in healthcare at Hope to Health Read More »
Understanding the dynamics within HIV transmission clusters is critical information that can help prioritize public health resource allocation. Although HIV sequence clustering is routinely used to identify subpopulations experiencing elevated transmission, there’s a risk of over-simplifying transmission dynamics within clusters as well as the risk that clustering methodology influences outcomes.
BC-CfE research advances understanding of dynamics within HIV transmission clusters Read More »
A new research report by the BC-CfE adds to the growing body of evidence that elderly individuals don’t mount as strong, or durable, immune responses to the COVID-19 vaccines as compared to younger individuals. This COVID-19 Immunity Task Force (CITF)-funded study was done in collaboration with Providence Health Care and Simon Fraser University. The study is currently in pre-print and has not yet been peer-reviewed.
BC-CfE studies immune response to COVID-19 vaccines among the elderly Read More »
A new research paper published by the BC-CfE laboratory’s scientists will help healthcare providers improve treatments for people living with the hepatitis C virus (HCV). The study, led by Dr. Hope Lapointe, describes a new test that physicians can use to help “personalize” their patients’ HCV treatment.
BC-CfE Researchers help fight drug resistance to Hepatitis C treatments Read More »
The BC-CfE’s Laboratory and its Director, Dr. Zabrina Brumme, are celebrating another recent success in being awarded grant funding for research. The BC-CfE, along with frequent collaborating partner Simon Fraser University, are now a part of the U.S.-based Research Enterprise to Advance a Cure for HIV (REACH) Collaboratory.
BC-CfE joins REACH Collaboratory in HIV cure research Read More »
The 11th International AIDS Society (IAS) Conference on HIV Science took place from July 18th to the 21st and BC-CfE researchers attending the virtual conference used the opportunity to present their latest findings. Taking place virtually from Berlin, IAS 2021 saw around 6,000 participants and opened with remarks from German Chancellor Angela Merkel and included
BC-CfE researchers attend world’s most influential meeting on HIV research Read More »
The Treatment Optimization of Psychosis (TOP) Collaborative officially launched on Wednesday, June 23rd. TOP is a quality improvement initiative led by the BC Centre for Excellence in HIV/AIDS (BC-CfE) in partnership with Vancouver Coastal Health’s (VCH) Mental Health and Substance Use Services. TOP aims to systematically share, measure and implement best practices in the treatment
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
